Philip Morris International Inc.: 10-K Risk Factor Changes

2025 vs 2024  ·  SEC EDGAR  ·  2026-10-16
Other years: 2026 vs 2025
⚠ AI Risk Brief Interpretation layer — deterministic data below

PM shifted focus to non-recreational cannabinoids and strategic M&A integration while shedding post-acquisition uncertainties from prior deals.

Direction ↔ Mixed
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

3
New Risks
3
Removed
7
Modified
23
Unchanged
🟢 New in Current Filing Disclosure change9/10

We may not successfully identify, complete, or realize the benefits from strategic acquisitions, divestitures, joint ventures, or investments.

🟢 New in Current Filing Our management uses certain key business metrics to evaluate our business, measure our performance, identify trends affecting our business, formulate financial projections and make strategic decisions and such metrics may not accurately reflect all of the aspects of our business needed to make such evaluations and decisions, in particular as our business continues to evolve. 🔒
🟢 New in Current Filing The research, development, and commercialization of non-recreational cannabinoid products subjects the Company to legal, regulatory, reputational and other risks. 🔒
🔴 No Match in Current Filing PMI, Swedish Match and Vectura Fertin Pharma may be subject to uncertainties that could adversely affect our respective businesses, and adversely affect the financial results of our combined businesses. 🔒

And 9 more changes in the full comparison.

12 changes in this historical filing

The complete historical comparison (2025 vs 2024) is available on the Pro plan.

Get Pro access Already a Pro subscriber? View full diff →